# ELYXYB
> **NDA212157** · New Drug Application · Sponsor: SCILEX PHARMS · Approved 2020-05-05
## Drug
- **FDA Application Number:** NDA212157
- **Application type:** New Drug Application
- **Brand name:** ELYXYB
- **Generic name:** CELECOXIB
- **Active ingredients:** CELECOXIB
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCILEX PHARMS
- **Manufacturer:** SCILEX PHARMACEUTICALS INC.
- **First approval:** 2020-05-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212157)
---
*MORVS · CC0 1.0*